These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31253177)

  • 1. Evolving neoantigen profiles in colorectal cancers with DNA repair defects.
    Rospo G; Lorenzato A; Amirouchene-Angelozzi N; Magrì A; Cancelliere C; Corti G; Negrino C; Amodio V; Montone M; Bartolini A; Barault L; Novara L; Isella C; Medico E; Bertotti A; Trusolino L; Germano G; Di Nicolantonio F; Bardelli A
    Genome Med; 2019 Jun; 11(1):42. PubMed ID: 31253177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.
    Germano G; Lamba S; Rospo G; Barault L; Magrì A; Maione F; Russo M; Crisafulli G; Bartolini A; Lerda G; Siravegna G; Mussolin B; Frapolli R; Montone M; Morano F; de Braud F; Amirouchene-Angelozzi N; Marsoni S; D'Incalci M; Orlandi A; Giraudo E; Sartore-Bianchi A; Siena S; Pietrantonio F; Di Nicolantonio F; Bardelli A
    Nature; 2017 Dec; 552(7683):116-120. PubMed ID: 29186113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue.
    Hirama T; Tokita S; Nakatsugawa M; Murata K; Nannya Y; Matsuo K; Inoko H; Hirohashi Y; Hashimoto S; Ogawa S; Takemasa I; Sato N; Hata F; Kanaseki T; Torigoe T
    JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34185709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
    van den Bulk J; Verdegaal EME; Ruano D; Ijsselsteijn ME; Visser M; van der Breggen R; Duhen T; van der Ploeg M; de Vries NL; Oosting J; Peeters KCMJ; Weinberg AD; Farina-Sarasqueta A; van der Burg SH; de Miranda NFCC
    Genome Med; 2019 Dec; 11(1):87. PubMed ID: 31888734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer.
    Yu Y; Zhang J; Ni L; Zhu Y; Yu H; Teng Y; Lin L; Xue Z; Xue X; Shen X; Song H; Su X; Sun W; Cai Z
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-11. PubMed ID: 33689574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.
    Newey A; Griffiths B; Michaux J; Pak HS; Stevenson BJ; Woolston A; Semiannikova M; Spain G; Barber LJ; Matthews N; Rao S; Watkins D; Chau I; Coukos G; Racle J; Gfeller D; Starling N; Cunningham D; Bassani-Sternberg M; Gerlinger M
    J Immunother Cancer; 2019 Nov; 7(1):309. PubMed ID: 31735170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A method of screening highly common neoantigens with immunogenicity in colorectal cancer based on public somatic mutation library].
    Qin LL; Li YJ; Liang ZR; Dai L; Li WH; Chen C; Huang YL; Zhang L; Liu SM; Qiu S; Ge YP; Peng WT; Lin XX; Zhang XQ; Dong X; Li B
    Yi Chuan; 2020 Jun; 42(6):599-612. PubMed ID: 32694118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer.
    Westcott PMK; Sacks NJ; Schenkel JM; Ely ZA; Smith O; Hauck H; Jaeger AM; Zhang D; Backlund CM; Beytagh MC; Patten JJ; Elbashir R; Eng G; Irvine DJ; Yilmaz OH; Jacks T
    Nat Cancer; 2021 Oct; 2(10):1071-1085. PubMed ID: 34738089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.
    O'Donnell T; Christie EL; Ahuja A; Buros J; Aksoy BA; Bowtell DDL; Snyder A; Hammerbacher J
    BMC Cancer; 2018 Jan; 18(1):87. PubMed ID: 29357823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets.
    Chen C; Liu S; Qu R; Li B
    Biomed Res Int; 2020; 2020():2861240. PubMed ID: 32733937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
    Chang K; Taggart MW; Reyes-Uribe L; Borras E; Riquelme E; Barnett RM; Leoni G; San Lucas FA; Catanese MT; Mori F; Diodoro MG; You YN; Hawk ET; Roszik J; Scheet P; Kopetz S; Nicosia A; Scarselli E; Lynch PM; McAllister F; Vilar E
    JAMA Oncol; 2018 Aug; 4(8):1085-1092. PubMed ID: 29710228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns.
    Li Z; Chen G; Cai Z; Dong X; He L; Qiu L; Zeng Y; Liu X; Liu J
    Chin J Cancer Res; 2021 Jun; 33(3):364-378. PubMed ID: 34321833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies.
    Lo AA; Wallace A; Oreper D; Lounsbury N; Havnar C; Pechuan-Jorge X; Wu TD; Bourgon R; Jones R; Krogh K; Yang GY; Zill OA
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neoantigen Landscape of Mycosis Fungoides.
    Sivanand A; Hennessey D; Iyer A; O'Keefe S; Surmanowicz P; Vaid G; Xiao Z; Gniadecki R
    Front Immunol; 2020; 11():561234. PubMed ID: 33329522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.
    Kalaora S; Wolf Y; Feferman T; Barnea E; Greenstein E; Reshef D; Tirosh I; Reuben A; Patkar S; Levy R; Quinkhardt J; Omokoko T; Qutob N; Golani O; Zhang J; Mao X; Song X; Bernatchez C; Haymaker C; Forget MA; Creasy C; Greenberg P; Carter BW; Cooper ZA; Rosenberg SA; Lotem M; Sahin U; Shakhar G; Ruppin E; Wargo JA; Friedman N; Admon A; Samuels Y
    Cancer Discov; 2018 Nov; 8(11):1366-1375. PubMed ID: 30209080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoantigen landscape dynamics during human melanoma-T cell interactions.
    Verdegaal EM; de Miranda NF; Visser M; Harryvan T; van Buuren MM; Andersen RS; Hadrup SR; van der Minne CE; Schotte R; Spits H; Haanen JB; Kapiteijn EH; Schumacher TN; van der Burg SH
    Nature; 2016 Aug; 536(7614):91-5. PubMed ID: 27350335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
    Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
    Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden.
    van den Bulk J; van der Ploeg M; Ijsselsteijn ME; Ruano D; van der Breggen R; Duhen R; Peeters KCMJ; Fariña-Sarasqueta A; Verdegaal EME; van der Burg SH; Duhen T; de Miranda NFCC
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36792124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome.
    Binder H; Hopp L; Schweiger MR; Hoffmann S; Jühling F; Kerick M; Timmermann B; Siebert S; Grimm C; Nersisyan L; Arakelyan A; Herberg M; Buske P; Loeffler-Wirth H; Rosolowski M; Engel C; Przybilla J; Peifer M; Friedrichs N; Moeslein G; Odenthal M; Hussong M; Peters S; Holzapfel S; Nattermann J; Hueneburg R; Schmiegel W; Royer-Pokora B; Aretz S; Kloth M; Kloor M; Buettner R; Galle J; Loeffler M
    J Pathol; 2017 Oct; 243(2):242-254. PubMed ID: 28727142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.